de Bart A C, Quax P H, Löwik C W, Verheijen J H
Gaubius Laboratory, TNO-PG, Leiden, The Netherlands.
J Bone Miner Res. 1995 Sep;10(9):1374-84. doi: 10.1002/jbmr.5650100915.
Plasmin-mediated extracellular proteolysis has been implicated in the degradation of bone in normal and pathological conditions. Normal and malignant osteoblasts can produce both tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA). We have used the osteosarcoma cell line MG63 to address the question of whether the enhanced bone turnover in osteosarcomas is mediated by t-PA or by u-PAA and to study the effect of the cytokine interleukin-1 alpha (IL-1 alpha), known to influence bone degradation, on the plasminogen activator production and extracellular matrix degradation in malignant osteoblastic cells. Furthermore, the effect of IL-1 alpha on the synthesis of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) was analyzed. u-PA production by MG63 was high (approximately 180 ng/10(6) cells/24 h). Also t-PA and PAI-1 production was observed. u-PA production was rapidly increased in MG63 by IL-1 alpha (10 ng/ml), whereas an effect on t-PA production was only found after a prolonged incubation and hardly any effect of IL-1 alpha on PAI-1 production was observed. mRNA analysis revealed similar effects. u-PA receptor (u-PAR) mRNA was detectable in MG63 cells and could be increased by IL-1 alpha after 24 h. In MG63, u-PA-mediated extracellular matrix degradation was detectable, and IL-1 alpha increased the u-PA-mediated matrix degradation (approximately 2-fold). Under control conditions in MG63, only MMP-2, TIMP-1, and TIMP-2 mRNA could be observed. After the addition of IL-1 alpha, a very rapid increase in MMP-1 and MMP-3 mRNA could be observed as well as a moderate increase in TIMP-1 mRNA. The presence of MMP-2 was demonstrated by gelatin zymography. These results show that IL-1 alpha can stimulate u-PA production and can regulate extracellular proteolytic activity mainly via u-PA induction in the MG63 osteosarcoma cell line. Furthermore, IL-1 alpha has a strong stimulating effect on the production of MMP-1 and MMP-3. These findings suggest that u-PA and possibly MMP-1 and MMP-3 play an important role in the process of bone turnover in osteosarcomas.
纤溶酶介导的细胞外蛋白水解作用在正常及病理状态下的骨降解过程中均有涉及。正常和成骨恶性细胞均可产生组织型纤溶酶原激活物(t-PA)和尿激酶型纤溶酶原激活物(u-PA)。我们利用骨肉瘤细胞系MG63来探讨骨肉瘤中骨转换增强是由t-PA还是u-PA介导的问题,并研究已知会影响骨降解的细胞因子白细胞介素-1α(IL-1α)对恶性成骨细胞中纤溶酶原激活物产生及细胞外基质降解的影响。此外,还分析了IL-1α对基质金属蛋白酶(MMPs)及其抑制剂(TIMPs)合成的影响。MG63细胞产生u-PA的量很高(约180 ng/10⁶个细胞/24小时)。同时也观察到了t-PA和PAI-1的产生。IL-1α(10 ng/ml)可使MG63细胞中u-PA的产生迅速增加,而对t-PA产生的影响仅在长时间孵育后才被发现,且几乎未观察到IL-1α对PAI-1产生有任何影响。mRNA分析显示了类似的结果。在MG63细胞中可检测到u-PA受体(u-PAR)mRNA,且24小时后IL-1α可使其增加。在MG63细胞中可检测到u-PA介导的细胞外基质降解,IL-1α可使u-PA介导的基质降解增加(约2倍)。在MG63细胞的对照条件下,仅可观察到MMP-2、TIMP-1和TIMP-2 mRNA。加入IL-1α后,可观察到MMP-1和MMP-3 mRNA迅速增加,TIMP-1 mRNA也有适度增加。通过明胶酶谱法证实了MMP-2的存在。这些结果表明,IL-1α可刺激u-PA的产生,并主要通过在MG63骨肉瘤细胞系中诱导u-PA来调节细胞外蛋白水解活性。此外,IL-1α对MMP-1和MMP-3的产生有强烈的刺激作用。这些发现提示u-PA以及可能的MMP-1和MMP-3在骨肉瘤骨转换过程中起重要作用。